Business
Bayer shares fall after losing Roundup trial
Bayer’s shares fell by 5% on Monday after it was ordered to pay $2.25bn to a Roundup user who developed cancer.
Bayer’s shares fell by 5% on Monday after it was ordered to pay $2.25bn to a Roundup user who developed cancer.